By Sougato Das, President and COO, LSN
RESI London 2025 will be the second year of the UK’s biggest life science investor conference. We expect 250 investors, ready to finance your company. The RESI partnering system allows you to schedule face to face meetings with each investor. See what last year’s attendees are saying!
Testimonials
“RESI London was an extremely productive experience for my company, and the partnering system was so easy to use.”
– Nick Sireau, CEO, Serenatis Bio
“RESI is the go-to meeting for biotech CEOs’ seeking early stage capital. They have built an early stage platform educating founders and bringing capital to them. They are the only people serving this under loved sub sector with such passion.”
– Sunil Shah, CEO, O2h Ventures & Co-founder, O2h Group
“Attending RESI London for the first time was a refreshing and highly positive experience. The event exceeded my expectations in several ways. The atmosphere was welcoming and collaborative, which created a conducive environment for meaningful interactions. What stood out most was the exposure to a unique group of investors—those with a specific interest in early-stage, cutting-edge technologies. These are exactly the type of investors we aim to connect with at Rinri, so the conference provided an excellent platform to engage with individuals who understand the risks and rewards of innovative science-driven ventures.”
– Simon Chandler, CEO, Rinri Therapeutics
“My session was punctual and well-organized. The jury members were thoughtfully selected and provided insightful, constructive feedback that was highly valuable.”
– Christine Ruckenbauer, CBO, RIANA Therapeutics
“I highly value RESI and am grateful for the opportunity both to contribute as a pitch judge, company scouting and the networking opportunities. You have a dynamic network with easy, friendly, professional access. Thanks for all you are doing for the life science and tech development sector.”
– Jill Sorensen, MTEC (Investor)
“As One Nucleus seeks to enable our members to engage with the widest possible investor pool, partnering with RESI London creates a unique opportunity to bring our members into contact with new global early-stage investors to complement the known local investors they meet at all other early-stage pitching events in the UK.”
– Tony Jones, CEO, One Nucleus
“We started this as a grassroots meeting with One Nucleus, and it has been extremely gratifying and rewarding to see our international investors attending because the UK, we know, has some great science that needs to get to the global stage. We are expecting 250+ investors.”
– Dennis Ford, CEO, Life Science Nation
Register RESI London by Friday, October 24 to save £200 on early bird rates!
| Register for RESI London | Appy to Pitch at RESI London |
Next Phase Newsletter 
Leave a comment